Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

What connects a broken windshield, a raccoon infestation and Peyronie’s disease? | What connects a broken windshield, a ...

The biopharma industry’s deal-a-palooza, better known as the J.P. Morgan Healthcare Conference, has kicked off in San ...

At $132 per share, J&J paid a 39% premium on Friday’s closing price of Intra-Cellular, a New York City based biotech that ...

Y-mAbs Therapeutics is parting ways with its chief commercial officer and putting a new hire in charge of the cancer drug ...

At the start of each of the last five years, the share price of Alkermes has increased. It’s the kind of steady trajectory ...

A yearslong partner of neuroscience player Sage, Biogen already owns 10.2% of the Cambridge, Massachusetts-based biotech, ...

BioDuro, which was formed in 2005 in San Diego and China originally as a CRO, merged with contract manufacturer Formex in ...

Nancy McGee, VP & GM, U.S. Patient Support Services, IQVIAJennifer Millard, VP, U.S. Integrated Patient Support Services, ...

Matt McNally is rejoining Publicis. The ad exec has taken the global CEO post at Publicis Health, returning to a company ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.